BCL2 and acute lymphoblastic leukemia: Correlative BH3 profiling confirmed frequent BCL2 and BCL-XL dependency in ALL cells, and the capacity for dependency switching during treatment as a potential mechanism of resistance to BCL2 inhibition [50].